New York Legislators Push State Law for Language Services at Pharmacies

New York City legislators and advocacy groups are pressing Albany to pass a law requiring every chain-store pharmacy in the state to provide language services so that customers can understand the medication they are taking. The proposed state law would be modelled on a city ordinance passed in 2009 that came into force in June.

The argument for it is not abstract. It is about a person standing at a counter holding a bottle they cannot read.

State Senator Jose Peralta, a Democrat from East Elmhurst, put it in blunter terms. Taking prescription medication, he said in a statement, should not be a game of Russian roulette for seniors, non-English speakers or anyone else, adding that he was committed to working with colleagues in the legislature to make medication instructions and prescription labels understandable to all consumers.

Who is behind the push

The initiative has assembled an unusually broad coalition. Alongside Peralta stand Assemblyman Richard Gottfried, a Manhattan Democrat and long-serving chair of the Assembly health committee, and City Councilwoman Julissa Ferreras of East Elmhurst. The organising work has come from the immigrant advocacy group Make the Road New York and the Health Justice Program at New York Lawyers for the Public Interest, which has taken on Make the Road as a client.

Nisha Agarwal, director of the Health Justice Program, said her programme and Make the Road had been working on the issue since 2007. The two organisations had collaborated on various health-care problems before settling on pharmacy labels, and they did so because of what the data showed.

The study that made the case

A New York Academy of Medicine study produced a set of numbers that are hard to argue with. Eighty-eight per cent of pharmacists reported seeing individuals with limited proficiency in English every single day. Almost eighty per cent said they had the capacity to translate labels. Yet only around thirty-nine per cent translated labels daily, and almost twenty-three per cent did not translate labels at all.

Read that again, because the gap is the whole story. The capability existed. It simply was not used. Software for producing translated labels was sitting on pharmacy computers, unopened, while customers walked out with instructions they could not follow.

The consequences of that gap are exactly what you would expect. Doses taken twice a day instead of once. Antibiotics abandoned halfway through a course. Medicines swallowed that were meant for the skin. Agarwal described the fundamental problem simply: the pharmacist could not explain to them how to take their medicine in a language they would understand.

Why pharmacies are the pressure point

Hospitals in the United States have been under language access obligations for years, backed by federal civil rights law and by accreditation standards. Pharmacies occupy a stranger position. They are the last professional contact a patient has before going home with a drug, and for many people they are the only contact. A patient who saw a doctor with an interpreter present may still leave the pharmacy with an English-only label.

Chain pharmacies are the obvious target for regulation because they have the resources. A national chain has centralised label-printing systems and can add a language field far more easily than an independent corner pharmacy can.

Translation is not the same as label translation

Getting this right is harder than it looks, which is one reason so many pharmacies quietly avoid it. Dosage instructions are dense, short and unforgiving. A label has almost no room, no context and no tolerance for ambiguity, which is why serious medical translation services treat pharmaceutical text as a specialism of its own rather than routine copy.

The known failure mode is automated translation used without review. New York City discovered this the hard way when machine-translated labels produced instructions that were merely strange in some cases and actively dangerous in others, including a patient told to take a medicine eleven times a day when the correct dose was once daily. The Spanish word for eleven is once. The software did not notice.

  • Standardised phrasing. A finite set of dosage instructions can be professionally translated once and reused, which removes most of the risk.
  • Human review. Machine output for medical text needs a qualified pair of eyes before it reaches a patient.
  • Verbal counselling. A translated label helps nobody who cannot read. Telephone interpreting at the counter fills that gap.

What happens next

The state bill faces the usual obstacles: retail lobbying, cost objections and a crowded legislative calendar. Supporters can point to a city law already operating, which undercuts the argument that compliance is impossible.

The wider context is a slow shift in how the American health system treats language. Federal guidance on limited English proficiency has existed for years without much enforcement, and researchers studying health literacy have shown repeatedly that patients who cannot read their instructions end up back in hospital. Guidance on patient rights and language access is published by the New York State Department of Health, but guidance is not the same as a requirement.

What advocates want is the requirement. A label a patient can read is a cheap intervention with an obvious payoff, and the study numbers suggest the machinery to deliver it is already installed and switched off.

The cost argument, examined

Opponents will raise cost, and the figure is worth interrogating. Adding a translated label to an existing print job is close to free once the phrasing has been prepared. The expensive part is verbal counselling, which requires either bilingual staff or a telephone interpreting contract billed by the minute. Set that against the price of the alternative. A patient readmitted to hospital after taking a drug incorrectly costs the system thousands of dollars, and Medicaid, not the pharmacy chain, usually pays that bill. Language access, framed as a spending line, looks like an expense. Framed as an outcome, it looks like one of the cheapest safety interventions available.